Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.25
0.06 (1.88%)
At close: Aug 15, 2025, 12:16 PM

Ekso Bionics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
14.65M 17.54M 17.93M 17.68M 18.16M 17.91M 18.28M 16.98M 15.71M 14.47M 12.91M 13.44M 13.16M 11.9M 11.25M 9.42M 9.27M 9.32M
Cost of Revenue
7.1M 8.18M 8.41M 8.52M 8.75M 8.88M 9.2M 8.6M 8.09M 7.46M 6.7M 6.49M 6.08M 5.18M 4.5M 3.73M 3.57M 3.66M
Gross Profit
7.55M 9.37M 9.51M 9.17M 9.41M 9.03M 9.08M 8.39M 7.62M 7M 6.21M 6.95M 7.07M 6.72M 6.75M 5.7M 5.7M 5.67M
Operating Income
-12.28M -10.64M -10.46M -11.68M -11.97M -13.92M -15.11M -16.1M -16.82M -15.77M -15.56M -15.67M -14.81M -14.93M -13.83M -12.27M -11.9M -11.65M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-11.09M -10.79M -11.33M -11.13M -12.42M -14.24M -15.2M -15.16M -16.1M -14.85M -15.08M -14.77M -12.42M -10.71M -9.76M -10.88M -6.47M -16.96M
Net Income
-11.09M -10.79M -11.33M -11.13M -12.42M -14.24M -15.01M -13.85M -15.43M -13.93M -14.74M -15.55M -12.55M -11.1M -9.76M -10.88M -6.47M -16.96M
Selling & General & Admin
16.37M 16.28M 16.1M 16.5M 16.66M 17.94M 19.17M 19.83M 20.01M 18.82M 17.97M 18.95M 18.52M 18.5M 17.83M 15.33M 14.79M 14.52M
Research & Development
3.46M 3.73M 3.87M 4.34M 4.72M 5.01M 5.02M 4.66M 4.43M 3.96M 3.8M 3.67M 3.35M 3.14M 2.75M 2.64M 2.62M 2.37M
Other Expenses
n/a n/a n/a -15K -12K -42K -47K -63K -62K -33K -28K 3K -1K n/a n/a n/a n/a n/a
Operating Expenses
19.83M 20.01M 19.97M 20.84M 21.38M 22.95M 24.19M 24.49M 24.44M 22.77M 21.77M 22.62M 21.88M 21.65M 20.58M 17.97M 17.42M 16.88M
Interest Expense
1K 140K 269K 276K 261K 248K 303K 303K 273K 241K 156K 126K 116K 114K 113K 103K 102K 113K
Selling & Marketing Expenses
7.04M 7.2M 7.31M 7.41M 7.7M 8.2M 8.47M 8.43M 8.12M 7.62M 7.16M 7.25M 7.2M 7.14M 7.3M 7.04M 7.1M 7.03M
Cost & Expenses
26.93M 28.19M 28.39M 29.36M 30.13M 31.83M 33.39M 33.08M 32.53M 30.23M 28.47M 29.11M 27.96M 26.83M 25.07M 21.7M 20.99M 20.54M
Income Tax Expense
n/a n/a n/a n/a n/a 31K -160K -1.29M -636K -918K -344K 782K 132K 383K n/a n/a n/a n/a
Shares Outstanding (Basic)
2.18M 25.39M 24.64M 20.31M 18.22M 17.42M 14.45M 14.07M 13.64M 13.3M 13.16M 13.07M 12.88M 12.73M 12.68M 12.66M 12.65M 10.75M
Shares Outstanding (Diluted)
2.18M 25.39M 24.64M 20.31M 18.22M 17.42M 14.45M 14.07M 13.64M 13.3M 13.16M 13.07M 12.88M 12.73M 12.68M 12.71M 12.74M 10.75M
EPS (Basic)
-1.6 -0.49 -0.57 -0.65 -0.79 -0.97 -1.09 -1.03 -1.17 -1.07 -1.14 -1.21 -0.98 -0.87 -0.82 -1.14 -0.69 -2.47
EPS (Diluted)
-1.6 -0.49 -0.57 -0.65 -0.79 -0.97 -1.09 -1.03 -1.17 -1.07 -1.14 -1.21 -0.98 -0.87 -0.82 -1.14 -1 -2.78
EBITDA
-11.96M -9.93M -9.45M -8.97M -10.34M -12.3M -13.18M -13.57M -14.71M -13.42M -14.04M -13.88M -11.55M -10.03M -9.09M -10.19M -5.79M -16.27M
EBIT
-8.31M -10.65M -11.06M -10.86M -12.16M -13.99M -14.89M -14.86M -15.83M -14.61M -14.92M -14.64M -12.3M -10.6M -9.65M -10.77M -6.37M -16.85M
Depreciation & Amortization
328K 725K 1.61M 1.89M 1.82M 1.69M 1.7M 1.28M 1.11M 1.17M 887K 762K 750K 566K 561K 586K 573K 582K